Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
3.310
+0.050 (1.53%)
At close: May 12, 2025, 4:00 PM
3.280
-0.030 (-0.91%)
After-hours: May 12, 2025, 4:59 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $106.57 million as of May 12, 2025. Its market cap has decreased by -19.92% in one year.
Market Cap
106.57M
Enterprise Value
-33.13M
1-Year Change
-19.92%
Ranking
Category
Stock Price
$3.31
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $106.57M, a decrease of -69.96%. That is a compound annual growth rate of -48.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 104.96M | -27.56% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |